84 related articles for article (PubMed ID: 19932124)
41. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
42. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
43. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival.
Williams SA; Ehlers RA; Hunt KK; Yi M; Kuerer HM; Singletary SE; Ross MI; Feig BW; Symmans WF; Meric-Bernstam F
Cancer; 2007 Aug; 110(4):731-7. PubMed ID: 17582626
[TBL] [Abstract][Full Text] [Related]
44. [Bone metastasis in breast carcinoma].
Kölbl O; Kiricuta IC; Willner J; Flentje M
Zentralbl Chir; 1997; 122(2):97-102. PubMed ID: 9173765
[TBL] [Abstract][Full Text] [Related]
45. Breast cancer dormancy can be maintained by small numbers of micrometastases.
Willis L; Alarcón T; Elia G; Jones JL; Wright NA; Tomlinson IP; Graham TA; Page KM
Cancer Res; 2010 Jun; 70(11):4310-7. PubMed ID: 20501854
[TBL] [Abstract][Full Text] [Related]
46. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
Hanin L
Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
[TBL] [Abstract][Full Text] [Related]
47. Suppression of Metastasis by Primary Tumor and Acceleration of Metastasis Following Primary Tumor Resection: A Natural Law?
Hanin L; Rose J
Bull Math Biol; 2018 Mar; 80(3):519-539. PubMed ID: 29302774
[TBL] [Abstract][Full Text] [Related]
48. Uncovering the natural history of cancer from post-mortem cross-sectional diameters of hepatic metastases.
Hanin L; Rose J
Math Med Biol; 2016 Dec; 33(4):397-416. PubMed ID: 26239139
[TBL] [Abstract][Full Text] [Related]
49. The evolution of tumor metastases during clonal expansion.
Haeno H; Michor F
J Theor Biol; 2010 Mar; 263(1):30-44. PubMed ID: 19917298
[TBL] [Abstract][Full Text] [Related]
50. Is There
Dujon AM; Capp JP; Brown JS; Pujol P; Gatenby RA; Ujvari B; Alix-Panabières C; Thomas F
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359593
[TBL] [Abstract][Full Text] [Related]
51. A "universal" model of metastatic cancer, its parametric forms and their identification: what can be learned from site-specific volumes of metastases.
Hanin L; Seidel K; Stoevesandt D
J Math Biol; 2016 May; 72(6):1633-62. PubMed ID: 26307099
[TBL] [Abstract][Full Text] [Related]
52. Identification of novel drugs to target dormant micrometastases.
Hurst RE; Hauser PJ; You Y; Bailey-Downs LC; Bastian A; Matthews SM; Thorpe J; Earle C; Bourguignon LY; Ihnat MA
BMC Cancer; 2015 May; 15():404. PubMed ID: 25971923
[TBL] [Abstract][Full Text] [Related]
53. Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model.
Uppal A; Wightman SC; Ganai S; Weichselbaum RR; An G
Theor Biol Med Model; 2014 Apr; 11():17. PubMed ID: 24725600
[TBL] [Abstract][Full Text] [Related]
54. Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth?
Retsky M; Demicheli R; Hrushesky W; Baum M; Gukas I
Cancers (Basel); 2010 Mar; 2(2):305-37. PubMed ID: 24281072
[TBL] [Abstract][Full Text] [Related]
55. Effects of Surgery and Chemotherapy on Metastatic Progression of Prostate Cancer: Evidence from the Natural History of the Disease Reconstructed through Mathematical Modeling.
Hanin L; Zaider M
Cancers (Basel); 2011 Sep; 3(3):3632-60. PubMed ID: 24212971
[TBL] [Abstract][Full Text] [Related]
56. Why victory in the war on cancer remains elusive: biomedical hypotheses and mathematical models.
Hanin L
Cancers (Basel); 2011 Jan; 3(1):340-67. PubMed ID: 24212619
[TBL] [Abstract][Full Text] [Related]
57. Modeling the connection between primary and metastatic tumors.
Diego D; Calvo GF; Pérez-García VM
J Math Biol; 2013 Sep; 67(3):657-92. PubMed ID: 22829353
[TBL] [Abstract][Full Text] [Related]
58. Does tumour dormancy offer a therapeutic target?
Goss PE; Chambers AF
Nat Rev Cancer; 2010 Dec; 10(12):871-7. PubMed ID: 21048784
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
